Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Oasmia Pharmaceutical signs new agreement with Baxter BioPharma Solutions
Oasmia Pharmaceutical AB (Sweden) announced that the company has signed a new five-year contract with Baxter BioPharma Solutions for global commercial manufacturing of Apealea.
Oasmia makes new distribution and marketing agreement concerning Russia
Oasmia Pharmaceutical, has entered into a new exclusive marketing and distributions agreement with Hetero Group with the goal of driving revenue in Russia and other CIS markets
Pharmasyntez Group of Companies
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
EXCELLENCE IN OLEOCHEMICAL EXCIPIENTS AND APIs
Active pharmaceutical substance for preparation of sterile and non-sterile drug products
Suitable for pharmaceutical oral & infusion formulations
Made in Germany
TOP 30 Pharmaceutical Contract Manufacturing Organisations
EAEU May Allow to Register Empty Primary Packages as Medical...
GMP Inspection Practice: a Case for Global Benchmarking, Con...
Regulation of Autogenous Vaccines
Inspection of Foreign Manufacturers of Veterinary Products
FDA Approved XCOPRI to Treat Partial-Onset Seizures
Subscribe to Newsletter!
© GMP news